Mylan Didn't Infringe Invalid Mirapex Patent: Judge
Boehringer Ingelheim Pharmaceuticals Inc. on Wednesday lost its bid to hold Mylan Pharmaceuticals Inc. accountable for allegedly infringing its patent covering restless leg syndrome treatment Mirapex after a federal judge agreed...To view the full article, register now.
Already a subscriber? Click here to view full article